Evolution of Cefiderocol Non-Susceptibility in Pseudomonas aeruginosa in a Patient Without Previous Exposure to the Antibiotic.
Ontology highlight
ABSTRACT: We report the emergence of non-susceptibility to cefiderocol from a subpopulation of Pseudomonas aeruginosa recovered from a patient without history of cefiderocol exposure. Whole genome sequencing identified mutations in major iron transport pathways previously associated with cefiderocol uptake. Susceptibility testing should be performed before therapy with siderophore cephalosporins.
SUBMITTER: Streling AP
PROVIDER: S-EPMC8825772 | biostudies-literature | 2021 Dec
REPOSITORIES: biostudies-literature
ACCESS DATA